BioCentury | Oct 13, 2020
Product Development

Data Bytes: coronavirus-targeted small molecules

...hospitalized COVID-19 patients.At least five other companies have SARS-CoV-2 3CLpro inhibitors in preclinical development: Anivive Lifesciences Inc., Cocrystal Pharma Inc....
BioCentury | Aug 8, 2020
Translation in Brief

Cocrystal’s COVID-19 antivirals; plus a portable breast cancer diagnostic, Tarveda mini-drug conjugate for solid tumors, and more

...one day after infection prevented mortality and reduced viral titers and edema in the lungs. Cocrystal Pharma Inc....
...80-6946 (Compound #), copanlisib (Generic) University of Iowa Kansas State University Tarveda Therapeutics Inc. Bayer AG Massachusetts General Hospital University of Basel Cocrystal Pharma Inc. Severe...
BioCentury | Jun 22, 2020
Emerging Company Profile

Prosit Sole: chimeric proteins for rare disease

...in development for norovirus infection include two nucleoside analogs: the Phase I compound CMX521 from Cocrystal Pharma Inc....
BioCentury | Jan 25, 2019
Clinical News

Cocrystal reports SVR12 rate of 67% for CC-31244 regimen

...or without a protease inhibitor to treat HCV infection is slated to start this quarter. Cocrystal Pharma Inc....
...the end of treatment Status: Preliminary Phase IIa data Milestone: Start Phase IIa (1Q19) Chris Lieu CC-31244, CDI-31244 Cocrystal Pharma Inc. Hepatitis...
BioCentury | Nov 30, 2018
Financial News

Pharmasset, Idenix vets lead HBV company Antios to $25M series A

...the expanding number of available HCV treatments. Most recently, Mayers was CMO of HCV company CoCrystal Pharma Inc....
BioCentury | Nov 27, 2018
Financial News

Pharmasset, Idenix vets lead HBV company Antios to $25M series A

...the expanding number of available HCV treatments. Most recently, Mayers was CMO of HCV company CoCrystal Pharma Inc....
BioCentury | Nov 9, 2018
Tools & Techniques

HitGen’s DNA for small molecules

...Ingelheim GmbH Screening Undisclosed Sept. 2017 Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) Screening Undisclosed Sept. 2017 CoCrystal Pharma Inc....
...house. The third model involves risk-sharing, with partners co-developing assets. Last year, HitGen partnered with CoCrystal Pharma Inc....
...Companies and Institutions Mentioned Aduro Biotech Inc., Berkeley, Calif. AstraZeneca plc (NYSE:AZN; LSE:AZN), London, U.K. CoCrystal Pharma Inc....
BioCentury | Sep 7, 2018
Financial News

Opko's Frost among those charged in ‘pump-and-dump’ schemes

...U.S. District Court for the Southern District of New York. Biozone Pharmaceuticals Inc. merged with Cocrystal Pharma Inc....
BioCentury | Oct 20, 2017
Company News

CoCrystal, HitGen, InterX develop small molecule drug candidates

...In September, CoCrystal Pharma Inc. (OTCQB:COCP), HitGen Ltd. (Chengdu, China) and software company InterX Inc. (Berkeley, Calif.) partnered...
...A joint steering committee will oversee the program. The companies did not respond to inquiries. CoCrystal Pharma Inc....
...OTCQB:COCP), Bothell, Wash. HitGen Ltd. , Chengdu, China InterX Inc., Berkeley, Calif. Business: High-throughput screening Shannon Lehnbeuter Cocrystal Pharma Inc. HitGen...
BioCentury | Sep 1, 2017
Clinical News

CoCrystal reports Phase I data for HCV candidate CC-31244

...mutation status and viral load. CC-31244 is a broad-spectrum HCV NS5B polymerase non-nucleoside inhibitor (NNI). CoCrystal Pharma Inc....
...pharmacokinetics HCV mutation status and HCV viral load Status: Phase Ia/Ib data Milestone: NA Elizabeth S. Eaton CC-31244 Cocrystal Pharma Inc. HCV...
Items per page:
1 - 10 of 16
BioCentury | Oct 13, 2020
Product Development

Data Bytes: coronavirus-targeted small molecules

...hospitalized COVID-19 patients.At least five other companies have SARS-CoV-2 3CLpro inhibitors in preclinical development: Anivive Lifesciences Inc., Cocrystal Pharma Inc....
BioCentury | Aug 8, 2020
Translation in Brief

Cocrystal’s COVID-19 antivirals; plus a portable breast cancer diagnostic, Tarveda mini-drug conjugate for solid tumors, and more

...one day after infection prevented mortality and reduced viral titers and edema in the lungs. Cocrystal Pharma Inc....
...80-6946 (Compound #), copanlisib (Generic) University of Iowa Kansas State University Tarveda Therapeutics Inc. Bayer AG Massachusetts General Hospital University of Basel Cocrystal Pharma Inc. Severe...
BioCentury | Jun 22, 2020
Emerging Company Profile

Prosit Sole: chimeric proteins for rare disease

...in development for norovirus infection include two nucleoside analogs: the Phase I compound CMX521 from Cocrystal Pharma Inc....
BioCentury | Jan 25, 2019
Clinical News

Cocrystal reports SVR12 rate of 67% for CC-31244 regimen

...or without a protease inhibitor to treat HCV infection is slated to start this quarter. Cocrystal Pharma Inc....
...the end of treatment Status: Preliminary Phase IIa data Milestone: Start Phase IIa (1Q19) Chris Lieu CC-31244, CDI-31244 Cocrystal Pharma Inc. Hepatitis...
BioCentury | Nov 30, 2018
Financial News

Pharmasset, Idenix vets lead HBV company Antios to $25M series A

...the expanding number of available HCV treatments. Most recently, Mayers was CMO of HCV company CoCrystal Pharma Inc....
BioCentury | Nov 27, 2018
Financial News

Pharmasset, Idenix vets lead HBV company Antios to $25M series A

...the expanding number of available HCV treatments. Most recently, Mayers was CMO of HCV company CoCrystal Pharma Inc....
BioCentury | Nov 9, 2018
Tools & Techniques

HitGen’s DNA for small molecules

...Ingelheim GmbH Screening Undisclosed Sept. 2017 Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) Screening Undisclosed Sept. 2017 CoCrystal Pharma Inc....
...house. The third model involves risk-sharing, with partners co-developing assets. Last year, HitGen partnered with CoCrystal Pharma Inc....
...Companies and Institutions Mentioned Aduro Biotech Inc., Berkeley, Calif. AstraZeneca plc (NYSE:AZN; LSE:AZN), London, U.K. CoCrystal Pharma Inc....
BioCentury | Sep 7, 2018
Financial News

Opko's Frost among those charged in ‘pump-and-dump’ schemes

...U.S. District Court for the Southern District of New York. Biozone Pharmaceuticals Inc. merged with Cocrystal Pharma Inc....
BioCentury | Oct 20, 2017
Company News

CoCrystal, HitGen, InterX develop small molecule drug candidates

...In September, CoCrystal Pharma Inc. (OTCQB:COCP), HitGen Ltd. (Chengdu, China) and software company InterX Inc. (Berkeley, Calif.) partnered...
...A joint steering committee will oversee the program. The companies did not respond to inquiries. CoCrystal Pharma Inc....
...OTCQB:COCP), Bothell, Wash. HitGen Ltd. , Chengdu, China InterX Inc., Berkeley, Calif. Business: High-throughput screening Shannon Lehnbeuter Cocrystal Pharma Inc. HitGen...
BioCentury | Sep 1, 2017
Clinical News

CoCrystal reports Phase I data for HCV candidate CC-31244

...mutation status and viral load. CC-31244 is a broad-spectrum HCV NS5B polymerase non-nucleoside inhibitor (NNI). CoCrystal Pharma Inc....
...pharmacokinetics HCV mutation status and HCV viral load Status: Phase Ia/Ib data Milestone: NA Elizabeth S. Eaton CC-31244 Cocrystal Pharma Inc. HCV...
Items per page:
1 - 10 of 16